Is APi Group (APG) Outperforming Other Business Services Stocks This Year?
Here is how APi (APG) and HNI (HNI) have performed compared to their sector so far this year.
APi (APG) Reports Next Week: Wall Street Expects Earnings Growth
APi (APG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why APi (APG) is a Great Momentum Stock to Buy
Does APi (APG) have what it takes to be a top stock pick for momentum investors? Let's find out.
Here is Why Growth Investors Should Buy APi (APG) Now
APi (APG) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Will APi (APG) Beat Estimates Again in Its Next Earnings Report?
APi (APG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Apogee Therapeutics: Funding Supports Best-In-Class Ambitions In Atopic Dermatitis
Apogee Therapeutics, Inc.'s APG777 shows best-in-class week-16 efficacy and quarterly/semi-annual dosing potential. In my view, this could give this drug candidate a great competitive profile. In fact, APG777 could potentially disrupt the massive AT market, which is currently dominated by Dupixent. APGE's Phase 2 trial, called APEX Part A, exceeded its targets. We also have to wait until 1H2026 for its maintenance data. Part B efficacy data is due by mid-2026.
Looking for a Growth Stock? 3 Reasons Why APi (APG) is a Solid Choice
APi (APG) possesses solid growth attributes, which could help it handily outperform the market.
APi (APG) Upgraded to Buy: What Does It Mean for the Stock?
APi (APG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Are Business Services Stocks Lagging APi Group (APG) This Year?
Here is how APi (APG) and INTERTEK GP (IKTSY) have performed compared to their sector so far this year.
3 Stock Split Stocks to Buy in June
Key Points Forward stock splits usually indicate very strong fundamentals.
Is APi Group (APG) Stock Outpacing Its Business Services Peers This Year?
Here is how APi (APG) and Cap Gemini SA (CGEMY) have performed compared to their sector so far this year.
Apogee Therapeutics: APG808 Asthma Treatment May Overtake Dupixent In IL-4Rα Class
Apogee Therapeutics, Inc. achieved positive interim results from phase 1b study using APG808 for the treatment of patients with Asthma. Interim 16-week data from the phase 2 APEX study using APG777 for the treatment of patients with AD expected mid-2025. The global asthma treatment market size is projected to reach $35.93 billion by 2034.
